动脉pH与脓毒性休克患者对血管加压素血流动力学反应的相关性:一项观察性队列研究
这项回顾性、多中心、观察性队列研究纳入8家医院2012年1月至2017年11月启动血管加压素作为儿茶酚胺辅助治疗的脓毒性休克患者1350例。启动时动脉pH 7.28±0.13、SOFA 14.1±3.5、乳酸5.6±4.6 mmol/L、去甲肾上腺素等效儿茶酚胺剂量32.3±25.4 µg/min。校正乳酸与SOFA后,动脉pH每低于7.40 0.1单位,血管加压素血流动力学反应 odds 降低(OR 0.79;95%CI 0.72-0.87);1小时去甲肾上腺素等效剂量增加1.5 µg/min(95%CI 0.5-2.5),6小时增加2.5 µg/min(95%CI 1.4-3.5)。作者认为与其他血管升压药类似,血管加压素的临床有效性在酸血症时似乎受损。
要点
- 血流动力学反应定义为启动血管加压素后6小时平均动脉压≥65 mm Hg且儿茶酚胺剂量下降。
- 1350例脓毒性休克患者启动血管加压素时pH 7.28±0.13、SOFA 14.1±3.5、乳酸5.6±4.6 mmol/L。
- 校正乳酸与SOFA后,pH每低于7.40 0.1单位,反应 odds 比0.79(95%CI 0.72-0.87)。
- pH每低于7.40 0.1单位,1小时去甲肾上腺素等效剂量增加1.5 µg/min(95%CI 0.5-2.5),6小时增加2.5 µg/min(95%CI 1.4-3.5)。
- 作者结论:与其他血管升压药类似,血管加压素在酸血症时的临床有效性似乎受损。
适用人群与场景
- 8家医院2012年1月至2017年11月启动血管加压素作为儿茶酚胺辅助治疗的脓毒性休克患者。
诊断标准与关键阈值
- 血流动力学反应:启动血管加压素后6小时平均动脉压≥65 mm Hg且儿茶酚胺剂量下降。
研究设计与关键结果
- 回顾性、多中心、观察性队列研究,纳入1350例脓毒性休克患者。
- 启动血管加压素时动脉pH 7.28±0.13、SOFA 14.1±3.5、乳酸5.6±4.6 mmol/L、去甲肾上腺素等效儿茶酚胺剂量32.3±25.4 µg/min。
- 校正乳酸与SOFA后,动脉pH每低于7.40 0.1单位,血管加压素血流动力学反应 odds 比0.79(95%CI 0.72-0.87)。
- pH每低于7.40 0.1单位,启动后1小时去甲肾上腺素等效儿茶酚胺剂量增加1.5 µg/min(95%CI 0.5-2.5),6小时增加2.5 µg/min(95%CI 1.4-3.5)。
证据类型、等级与局限
- 证据类型:回顾性、多中心、观察性队列研究。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,与其他血管升压药类似,血管加压素的临床有效性在酸血症时似乎受损。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Vasopressin is reported to retain vasoconstrictive activity in the setting of acidemia, but preclinical models are inconsistent and studies have not evaluated the clinical effectiveness of vasopressin based on arterial pH. This study sought to determine the association between arterial pH and blood pressure after vasopressin initiation in septic shock.
DESIGN: This retrospective, multicenter, observational cohort study evaluated the association of arterial pH at the time of vasopressin initiation with hemodynamic response to vasopressin and change in catecholamine dose after vasopressin initiation. Hemodynamic response was defined as a catecholamine dose decrease with mean arterial pressure greater than or equal to 65 mm Hg at 6 hours after vasopressin initiation.
SETTING: Patients from eight hospitals in a health system were evaluated.
PATIENTS: Patients with septic shock initiated on vasopressin as a catecholamine adjunct between January 2012 and November 2017 were screened for inclusion.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: A total of 1,350 patients were included. At the time of vasopressin initiation patients were severely ill with arterial pH 7.28 ± 0.13, Sequential Organ Failure Assessment 14.1 ± 3.5, lactate 5.6 ± 4.6 mmol/L, and norepinephrine-equivalent catecholamine dose 32.3 ± 25.4 µg/min. After adjusting for lactate and Sequential Organ Failure Assessment with multivariable logistic regression, lower arterial pH was independently associated with lower odds of hemodynamic response to vasopressin (for each 0.1 unit arterial pH was below 7.40, response odds ratio 0.79; 95% CI, 0.72-0.87). For each 0.1 unit the pH was below 7.40 at vasopressin initiation, the norepinephrine-equivalent catecholamine dose increased by 1.5 µg/min (95% CI, 0.5-2.5 µg/min) at 1 hour, and increased by 2.5 µg/min (95% CI, 1.4-3.5 µg/min) at 6 hours after vasopressin initiation.
CONCLUSIONS: Compared with higher arterial pH, patients with septic shock and low arterial pH had lower odds of vasopressin response and higher catecholamine doses after vasopressin initiation. Similar to other vasopressors, the clinical effectiveness of vasopressin appears to be impaired in the setting of acidemia.
参考来源
- Bauer SR, Sacha GL, Siuba MT, et al. Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study. Crit Care Explor. 2022. PMID: 35156051. doi:10.1097/CCE.0000000000000634
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。